Viewing nowLipistin Tablets 10 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 10.36mg
Tablet · Prescription medication
Bukwang Pharmaceutical Co., Ltd.

MFDS item code 201403178 · Approved 2014.07.16 · Insurance code 642203430
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication helps reduce the risk of cardiovascular diseases. It decreases the risk of myocardial infarction, stroke, vascular surgeries, and angina in adults with various risk factors related to coronary heart disease and in patients with type 2 diabetes. Additionally, it reduces the risks of myocardial infarction, stroke, congestive heart failure hospitalizations, and angina, effectively lowering cholesterol and lipid levels in hyperlipidemia patients while increasing HDL-cholesterol levels. It is also safe to use in pediatric patients with heterozygous familial hypercholesterolemia to help decrease cholesterol levels. This medication is useful in improving various risk factors for cardiovascular diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily; however, patients requiring greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (only for those requiring an LDL cholesterol reduction of 45 % or more). This medicine is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized based on patient characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: The efficacy and safety in patients aged 70 years and older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose of this medicine is 10 mg once daily, and the recommended maximum dose is 20 mg per day (there are no clinical data on doses greater than 20 mg in pediatric patients). Adjust the dose as appropriate according to the recommended treatment goals for each patient. The dose should be adjusted at intervals of 4 weeks or longer.
This medication carries a risk of muscle problems, so if symptoms of muscle pain or weakness occur, discontinue use immediately and consult a physician. It may affect liver function, so it should not be used in individuals with liver disease or elevated liver enzyme levels. Pregnant women or those who may become pregnant should avoid this medication and should use adequate contraception while on it. It is not to be used in children under the age of 10 and should be avoided during breastfeeding. Drug interactions may increase the risk of side effects, so inform your doctor or pharmacist about any medications you are taking. Patients with a history of excessive alcohol consumption or liver disease should use this medication cautiously. Elderly patients or those with reduced renal function are at a higher risk for muscle-related side effects, necessitating caution during use. Regular monitoring of liver function and muscle health is recommended; if abnormalities are detected, treatment should be stopped immediately. This medication contains lactose, so patients with lactose intolerance should not take it. There is no specific antidote for overdose, so appropriate treatment should be given based on symptoms, and liver function and muscle enzyme levels should be monitored. Keep out of reach of children and store in its original container to prevent quality degradation.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it is important to store it in a sealed container. The storage temperature should be kept between 1 to 30 degrees Celsius, avoiding excessively hot or cold environments.
White oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 10.36mg
Tablet · Prescription medication
Bukwang Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.